Norman M. Betts - 29 Nov 2021 Form 4 Insider Report for BIOTRICITY INC. (BTCY)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
06 Dec 2021, 14:16:58 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Norman M. Betts

Key filing fact

Norman M. Betts filed Form 4 for BIOTRICITY INC. (BTCY) on 06 Dec 2021.

Key facts

  • This page summarizes Norman M. Betts's Form 4 filing for BIOTRICITY INC. (BTCY).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Dec 2021, 14:16.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BTCY transaction

Common Stock

Award

Transaction value
$0
Shares
+54,348
Change %
+17%
Price
$0.000000
Shares after
375,598
Date
29 Nov 2021
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Granted in connection with the Reporting Person's service on the Company's board. Such shares were issued pursuant the Company's 2016 Equity Incentive Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .